Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 67877-511

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 67877-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin 10mg 10s Blister

Atorvastatin 10mg 10s Blister
This is a medication with the code number DD/DRUGS/DD/230 used under prescription-only (Rx Only) that contains Atorvastatin Calcium. Each tablet of the medication contains 10 mg of base. The medication is distributed by Ascend Laboratories in Parsippany, NJ, and manufactured in India. The remaining characters are not recognizable.*
FDA Label Image

Atorvastatin 10mg 10s Cart

FDA Label Image

Atorvastatin 10mg 90s Tab

Atorvastatin 10mg 90s Tab
Atorvastatin Calcium Tablets contain 10mg of atorvastatin and are stored at controlled room temperature. The tablets should be kept in tight containers out of the reach of children. Full prescribing information can be found in the package insert. The manufacturer is Alkem Laboratories Ltd. and they are distributed by Ascend Laboratories, LLC. The code number is not provided.*
FDA Label Image

Atorvastatin 20mg 500s Tab

Atorvastatin 20mg 500s Tab
This is a description for Atorvastatin Calcium Tablets USP. Each film-coated tablet contains 20mg of Atorvastatin Calcium. The tablets should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F). The usual dosage should be based on the package insert for full prescribing information. Atorvastatin Calcium Tablets should be kept out of the reach of children and should be dispensed in tight containers. The manufacturer is Alkem Laboratories Ltd., and the product is distributed by Ascend Laboratories, LLC.*
FDA Label Image

Atorvastatin 40mg 1000s Tab

Atorvastatin 40mg 1000s Tab
Each tablet of this medicine contains Atorvastatin Calcium, USP equivalent to 40 mg of Atorvastatin. It is recommended to store the medication at a controlled room temperature and in tight containers. The usual dosage should be as per the package insert. This medicine is to be kept out of the reach of children. The tablets are manufactured in India by Akem Laboratories Ltd and distributed by Ascend Laboratories, LLC in Parsippany, NJ. The NDC number is 67877-513-10.*
FDA Label Image

Atorvastatin 80mg 1000s Tab

Atorvastatin 80mg 1000s Tab
This medication contains Atorvastatin Calcium and is dispensed in tight containers. The usual dosage can be found in the package insert. It is important to store the tablets in a controlled room temperature area. This product is manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories in Parsippany, NJ. The size and shape of the tablets are 64 x 39 mm. It is recommended to keep this medication out of the reach of children.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
This text presents data on the cumulative hazard percentage for a clinical trial comparing placebo to atorvastatin, a commonly used medication for lipid-lowering. The hazard ratio (HR) is reported as 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001, suggesting that atorvastatin significantly reduces the risk of experiencing the primary endpoint over the course of four years. However, without knowing what the primary endpoint is, it is difficult to draw further conclusions. A survival curve is presented, showing time-to-event data over the four-year follow-up period.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
This is a medication study report that shows the percentage of subjects experiencing a cardiovascular event while taking Atorvastatin at two different doses (10mg and 80mg). The results indicate that Atorvastatin 80mg had a lower risk of cardiovascular events compared to Atorvastatin 10mg, with a Hazard Ratio (HR) of 0.78 (p=0.0002). The study also includes a chart showing the time to the first major cardiovascular endpoint over four years.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.